Results 271 to 280 of about 28,282,310 (344)

Interplay of Interleukin-1<b>β</b> and Curcumin on VEGF Expression in Breast Cancer Cells. [PDF]

Oncol Res
Nass N, Ignatov A, Kalinski T.
europepmc   +1 more source

Leveraging Macrophage Metabolic Reprogramming for Enhanced Anti‐Tumor Immunity

Advanced Science, EarlyView.
Tumor‐associated macrophages (TAMs) are key regulators of the tumor microenvironment (TME), with their metabolic states playing a critical role in tumor progression or regression. This review summarizes current understanding of TAM metabolic plasticity alongside cutting‐edge bioengineering innovations, outlining a roadmap for transforming the ...
Zhiyun Liu, Lingyao Zeng, Xulin Gan, Yilin Zhou, Han Shen, Dan Wu, Xin Shou, Minmin Jiang, Liyun Shi   +8 more
wiley   +1 more source

Comparative Efficacy and Safety of Colchicine and Anti-Interleukin-1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials. [PDF]

J Am Heart Assoc
Ehsan M, Syed AB, Mustafa B, Ikram J, Khan MH, Cremer PC, Imazio M, Wang TKM, Klein AL.   +8 more
europepmc   +1 more source

Heparan sulfate fine-tuned interleukin-1 (IL-1) signaling inhibits insulin secretion of grafted pancreatic islets. [PDF]

Sci Adv
Wrublewsky S, Rother S, Pohlemann F, Radanovic T, Junker F, Boewe AS, Schunk S, Roma LP, Ruiz-Gómez G, Pisabarro MT, MacDonald PE, Menger MD, Laschke MW, Ampofo E.   +13 more
europepmc   +1 more source

Diagnosis, management, and monitoring of interleukin-1 mediated diseases in Central and Eastern Europe: real-world data. [PDF]

Pediatr Rheumatol Online J
Jelusic M, Sestan M, Toplak N, Tamas C, Vojinovic J, Zuber Z, Wolska-Kusnierz B, Sparchez M, Jesenak M, Rusoniene S, Stanevica V, Dolezalova P, Harel L, Uziel Y, Gattorno M.   +14 more
europepmc   +1 more source

The correlation between Interleukin 1 β (IL-1β) as an inflammatory marker and Malondialdehyde (MDA) as a lipid peroxidation marker and the development of cardiac and pancreatic complications in humans suspected to scorpion poisoning. [PDF]

BMC Pharmacol Toxicol
Mebed GR, Zakaria MS, Setouhi A, Rezk MNN.   +3 more
europepmc   +1 more source

The Arabidopsis TIRome informs the design of artificial TIR (Toll/interleukin-1 receptor) domain proteins

Bayless AM, Song L, Sorbello M, Ogden SC, Todd TS, Flint A, Maruta N, Tulu J, Drenichev M, Ntoukakis V, Ve T, Mobli M, Wan L, Liu Q, Dangl JL, Kobe B, Grant M, Nishimura MT.   +17 more
europepmc   +1 more source

Interleukin-1 polymorphisms associated with increased risk of gastric cancer [PDF]

Nature, 2000
Helicobacter pylori infection is associated with a variety of clinical outcomes including gastric cancer and duodenal ulcer disease. The reasons for this variation are not clear, but the gastric physiological response is influenced by the severity and ...
E. El-Omar, M. Carrington, W. Chow, K. McColl, J. Bream, H. Young, Jesus Herrera, J. Lissowska, Chiu-Chin Yuan, N. Rothman, G. Lanyon, Maureen P. Martin, J. Fraumeni, C. Rabkin   +13 more
semanticscholar   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Biology of interleukin 1

The FASEB Journal, 1988
Interleukin 1 (IL 1) is a polypeptide that is produced after infection, injury, or antigenic challenge. Although the macrophage is a primary source of IL 1, epidermal, epithelial, lymphoid, and vascular tissues synthesize IL 1.
C. Dinarello
semanticscholar   +3 more sources